Intrinsic Value of S&P & Nasdaq Contact Us

Cochlear Limited CHEOY OTC

Other OTC • Healthcare • Medical - Devices • AU • USD

SharesGrow Score
87/100
7/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$318.50
+407.2%

Cochlear Limited (CHEOY) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Sydney, NSW, Australia. The current CEO is Diggory William Howitt.

CHEOY has IPO date of 2010-04-05, 4,996 full-time employees, listed on the Other OTC, a market capitalization of $8.25B.

About Cochlear Limited

Cochlear Limited is a global medical device company specializing in implantable hearing solutions for both adults and children. The company develops and markets cochlear implant systems, sound processor upgrades, bone conduction systems, and related accessories designed to restore hearing function for individuals with moderate to profound hearing loss. Founded in 1981 and headquartered in Sydney, Australia, Cochlear operates internationally and serves patients across diverse markets worldwide.

📍 1 University Avenue, Sydney, NSW 2109 📞 61 2 9428 6555
Company Details
SectorHealthcare
IndustryMedical - Devices
CountryAustralia
ExchangeOther OTC
CurrencyUSD
IPO Date2010-04-05
CEODiggory William Howitt
Employees4,996
Trading Info
Current Price$62.80
Market Cap$8.25B
52-Week Range56.07-105.6
Beta0.51
ETFNo
ADRYes
CUSIP191459205
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message